Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated EPS 2008–2025
Vertex Pharmaceuticals Incorporated annual/quarterly eps history and growth rate from 2008 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Vertex Pharmaceuticals Incorporated eps for the quarter ending March 31, 2026 was $4.02, a 61.45% increase year-over-year.
- Vertex Pharmaceuticals Incorporated annual eps for 2025 was $15.32, a 836.54% decrease from 2024.
- Vertex Pharmaceuticals Incorporated annual eps for 2024 was $2.08, a 114.97% decrease from 2023.
- Vertex Pharmaceuticals Incorporated annual eps for 2023 was $13.89, a 8.35% increase from 2022.
- Vertex Pharmaceuticals Incorporated annual eps for 2022 was $12.82.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Vertex Pharmaceuticals Inc. EPS — FAQ
Vertex Pharmaceuticals Inc. (VRTX) eps over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Vertex Pharmaceuticals Inc.'s eps?
Vertex Pharmaceuticals Inc. (VRTX) reported eps of $15.32 for fiscal 2025.
Where can I see VRTX's eps history?
The chart and table above show Vertex Pharmaceuticals Inc.'s eps by year and by quarter, including the growth rate.